Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) (RABAMES)
Sponsor: Coordination center for clinical studies, Mainz, Germany
Listed as NCT00562406, this NA trial focuses on Macular Edema and remains completed. Sponsored by Coordination center for clinical studies, Mainz, Germany, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Coordination center for clinical studies, Mainz, Germany
- Klinikum Ludwigshafen
- Norvartis Pharma, Nuremberg, Germany
For direct contact, visit the study record on ClinicalTrials.gov .